Equate Cherry Zinc Cold Relief Lozenges
Zincum Gluconicum
Walmart
Human Otc Drug
NDC 49035-323Equate Cherry Zinc Cold Relief Lozenges also known as Zincum Gluconicum is a human otc drug labeled by 'Walmart'. National Drug Code (NDC) number for Equate Cherry Zinc Cold Relief Lozenges is 49035-323. This drug is available in dosage form of Lozenge. The names of the active, medicinal ingredients in Equate Cherry Zinc Cold Relief Lozenges drug includes Zinc Gluconate - 2 [hp_X]/1 . The currest status of Equate Cherry Zinc Cold Relief Lozenges drug is Active.
Drug Information:
| Drug NDC: | 49035-323 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Equate Cherry Zinc Cold Relief Lozenges |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Zincum Gluconicum |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Walmart |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Lozenge |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ZINC GLUCONATE - 2 [hp_X]/1
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 02 Aug, 2019 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 15 Jan, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Walmart
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0681131296236
|
| UPC stands for Universal Product Code. |
| UNII: | U6WSN5SQ1Z
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class: | Copper Absorption Inhibitor [EPC]
Decreased Copper Ion Absorption [PE]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 49035-323-18 | 18 LOZENGE in 1 CARTON (49035-323-18) | 02 Aug, 2019 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose cold relief
Product Elements:
Equate cherry zinc cold relief lozenges zincum gluconicum zinc gluconate zinc cation water b semi-translucent
Indications and Usage:
Uses reduce the duration of nasal congestion and shorten the length of the common cold
Warnings:
Warnings ask a doctor before use if you have a sensitivity to zinc or are allergic to zinc or any of the other ingredients in this product.
When Using:
When using this product to avoid minor stomach upset, do not dissolve lozenge on an empty stomach avoid citrus fruits or juices and products containing citric acid 1/2 hours before or after taking, as they may diminish effectiveness
Dosage and Administration:
Directions adults and children 12 years and over for best results, begin treatment at start of symptoms (within 24 - 48 hours of onset) completely dissolve lozenge in mouth. (do not swallow whole. do not chew) repeat every 2 - 4 hours as needed until symptoms subside do not exceed 6 lozenges for adults and 4 lozenges for children ages 12 - 17 in a 24 hour period for children under 12 years of age, consult a health professional prior to use
Stop Use:
Stop use and ask a doctor if symptoms persists for more than 7 days or are accompanied by a fever
Package Label Principal Display Panel:
Equate cherry zinc 18ct lozenges
Further Questions:
Questions? or to report an adverse event call 1-800-245-2898. monday - friday. 9am to 4pm est